Original Research

Accepted on 08 May 2024

Single-cell profiling indicates a high similarity between immune cells in the cerebrospinal fluid and in meningeal ectopic lymphoid tissue in experimental autoimmune encephalomyelitis

in Multiple Sclerosis and Neuroimmunology

Tanya Georgieva
Jolien Diddens
Verena Friedrich
Gildas Lepennetier
Rosa M Brand
Klaus Lehmann-Horn

Frontiers in Immunology

doi 10.3389/fimmu.2024.1400641

Case Report

Accepted on 07 May 2024

Recurrent CNTN1 antibody-positive nodopathy: a case report and literature review

in Multiple Sclerosis and Neuroimmunology

Min Zhao
Guixian Chen
Shuguang Li
Xiaojun Li
Haoxuan Chen
Zhenzhen Lou
Huiying Ouyang
Yibo Zhan
Chenghao Du
Yuanqi Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1368487

Brief Research Report

Accepted on 06 May 2024

Elevated serum levels of anti-collagen type I antibodies in patients with spontaneous cervical artery dissection and ischemic stroke: A prospective multicenter study

in Multiple Sclerosis and Neuroimmunology

Silke Zimmermann
Markus Weißenfels
Norma Krümmer
Wolfgang Härtig
Gesa Weise
Daniela Branzan
Dominik Michalski
Johann Pelz

Frontiers in Immunology

doi 10.3389/fimmu.2024.1348430

Original Research

Published on 03 May 2024

Investigation into the restoration of TRPM3 ion channel activity in post-COVID-19 condition: a potential pharmacotherapeutic target

in Multiple Sclerosis and Neuroimmunology

Etianne Martini Sasso
Katsuhiko Muraki
Natalie Eaton-Fitch
Peter Smith
Andrew Jeremijenko
Paul Griffin
Sonya Marshall-Gradisnik

Frontiers in Immunology

doi 10.3389/fimmu.2024.1264702

1,544 views

Brief Research Report

Published on 03 May 2024

Dimethyl fumarate modulates the regulatory T cell response in the mesenteric lymph nodes of mice with experimental autoimmune encephalomyelitis

in Multiple Sclerosis and Neuroimmunology

Amanda D. R. Lima
Breno B. Ferrari
Fernando Pradella
Rodrigo M. Carvalho
Sandra L. S. Rivero
Raphael P. S. Quintiliano
Matheus A. Souza
Natália S. Brunetti
Ana M. Marques
Irene P. Santos

Frontiers in Immunology

doi 10.3389/fimmu.2024.1391949

219 views

Original Research

Published on 30 Apr 2024

Gas6/TAM system as potential biomarker for multiple sclerosis prognosis

in Multiple Sclerosis and Neuroimmunology

Davide D’Onghia
Donato Colangelo
Mattia Bellan
Stelvio Tonello
Chiara Puricelli
Eleonora Virgilio
Daria Apostolo
Rosalba Minisini
Luciana L. Ferreira
Leonardo Sozzi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1362960

239 views

Original Research

Published on 30 Apr 2024

H-intensity scale score to estimate CSF GluN1 antibody titers with one-time immunostaining using a commercial assay

in Multiple Sclerosis and Neuroimmunology

Masaki Iizuka
Naomi Nagata
Naomi Kanazawa
Tomomi Iwami
Makoto Nagashima
Masaaki Nakamura
Juntaro Kaneko
Eiji Kitamura
Kazutoshi Nishiyama
Noritaka Mamorita

Frontiers in Immunology

doi 10.3389/fimmu.2024.1350837

309 views

Original Research

Published on 30 Apr 2024

Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Cathérine Dekeyser
Pieter De Kesel
Melissa Cambron
Ludo Vanopdenbosch
Liesbeth Van Hijfte
Martine Vercammen
Guy Laureys

Frontiers in Immunology

doi 10.3389/fimmu.2024.1385231

201 views

Original Research

Accepted on 29 Apr 2024

CAP2 contributes to Parkinson's disease diagnosed by neutrophil extracellular trap-related immune activity

in Multiple Sclerosis and Neuroimmunology

Li Xiaohe
Meiling Luo
Hangrui Xu
Lei Jia
Yanan Liang
Qianxi Xu
Yonghui Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1377409

Original Research

Published on 29 Apr 2024

Interactions between circulating inflammatory factors and autism spectrum disorder: a bidirectional Mendelian randomization study in European population

in Multiple Sclerosis and Neuroimmunology

Junzi Long
Hui Dang
Wenlong Su
Md. Moneruzzaman
Hao Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1370276

260 views

Original Research

Accepted on 26 Apr 2024

Serum NfL and EGFR/NfL ratio mRNAs as biomarkers for phenotype and disease severity of myelin oligodendrocyte glycoprotein IgG-associated disease

in Multiple Sclerosis and Neuroimmunology

Xin Wang
Yi Qu
Jiayu Fan
Huiqiang Ren

Frontiers in Immunology

doi 10.3389/fimmu.2024.1388734

Original Research

Accepted on 25 Apr 2024

A Helping HAND: Therapeutic Potential of MAGL Inhibition Against HIV-1-associated Neuroinflammation

in Multiple Sclerosis and Neuroimmunology

Alexis Fraser League
Barkha J Yadav-Samudrala
Ramya Kolagani
Calista Cline
Ian Randolph Jacobs
Jonathan Manke
Micah Niphakis
Benjamin Cravatt
Aron Lichtman
Bogna Ignatowska-Jankowska

Frontiers in Immunology

doi 10.3389/fimmu.2024.1374301

Original Research

Published on 25 Apr 2024

Exploring the common mechanism of vascular dementia and inflammatory bowel disease: a bioinformatics-based study

in Multiple Sclerosis and Neuroimmunology

Yujiao Wang
Daojun Xie
Shijia Ma
Nan Shao
Xiaoyan Zhang
Xie Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1347415

169 views

Original Research

Accepted on 22 Apr 2024

Case report: Tumefactive demyelinating lesions after the 2nd cycle of alemtuzumab in multiple sclerosis; immune cell profile and biomarkers

in Multiple Sclerosis and Neuroimmunology

Neus Rabaneda-Lombarte
Aina Teniente-Serra
Anna Massuet-Vilamajó
Cristina M Ramo-Tello
Silvia Presas-Rodríguez

Frontiers in Immunology

doi 10.3389/fimmu.2024.1395749

Systematic Review

Published on 16 Apr 2024

Risk of secondary autoimmune diseases with alemtuzumab treatment for multiple sclerosis: a systematic review and meta-analysis

in Multiple Sclerosis and Neuroimmunology

Jianguo Yang
Yuying Sun
Xinpeng Zhou
Di Zhang
Ziqi Xu
Jiaojiao Cao
Bing Fan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1343971

593 views

Case Report

Published on 11 Apr 2024

Case report: Atypical case of autoimmune glial fibrillary acidic protein astrocytopathy following COVID-19 vaccination refractory to immunosuppressive treatments

in Multiple Sclerosis and Neuroimmunology

Yuto Morishima
Takanori Hata
Sho Nakajima
Kazumasa Shindo
Mai Tsuchiya
Tsubasa Watanabe
Ippei Tahara
Tetsuo Kondo
Akio Kimura
Takayoshi Shimohata

Frontiers in Immunology

doi 10.3389/fimmu.2024.1361685

959 views

Navigation group

Articles

Single-cell profiling indicates a high similarity between immune cells in the cerebrospinal fluid and in meningeal ectopic lymphoid tissue in experimental autoimmune encephalomyelitis

Recurrent CNTN1 antibody-positive nodopathy: a case report and literature review

Elevated serum levels of anti-collagen type I antibodies in patients with spontaneous cervical artery dissection and ischemic stroke: A prospective multicenter study

Investigation into the restoration of TRPM3 ion channel activity in post-COVID-19 condition: a potential pharmacotherapeutic target

Dimethyl fumarate modulates the regulatory T cell response in the mesenteric lymph nodes of mice with experimental autoimmune encephalomyelitis

Gas6/TAM system as potential biomarker for multiple sclerosis prognosis

H-intensity scale score to estimate CSF GluN1 antibody titers with one-time immunostaining using a commercial assay

Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis

CAP2 contributes to Parkinson's disease diagnosed by neutrophil extracellular trap-related immune activity

Interactions between circulating inflammatory factors and autism spectrum disorder: a bidirectional Mendelian randomization study in European population

Serum NfL and EGFR/NfL ratio mRNAs as biomarkers for phenotype and disease severity of myelin oligodendrocyte glycoprotein IgG-associated disease

A Helping HAND: Therapeutic Potential of MAGL Inhibition Against HIV-1-associated Neuroinflammation

Exploring the common mechanism of vascular dementia and inflammatory bowel disease: a bioinformatics-based study

Case report: Tumefactive demyelinating lesions after the 2nd cycle of alemtuzumab in multiple sclerosis; immune cell profile and biomarkers

Risk of secondary autoimmune diseases with alemtuzumab treatment for multiple sclerosis: a systematic review and meta-analysis

Case report: Atypical case of autoimmune glial fibrillary acidic protein astrocytopathy following COVID-19 vaccination refractory to immunosuppressive treatments